PARKER H STEWART
Insider CIK 1217456 · SGMO Director · CDXS Director · IMPL Director · ARMP Director · OGXI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDXS CODEXIS, INC. | A Award deriv | 2026-06-17 | 2026-06-18 | 66,350 | — | $0 | 66,350 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2025-06-12 | 2025-06-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2025-06-12 | 2025-06-16 | 25,000 | — | $0 | 112,600 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-06-10 | 2025-06-12 | 40,983 | — | $0 | 143,583 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2024-06-11 | 2024-06-13 | 30,120 | — | $0 | 102,600 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2024-06-04 | 2024-06-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2024-06-04 | 2024-06-06 | 25,000 | — | $0 | 87,600 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2023-06-13 | 2023-06-15 | 34,602 | — | $0 | 72,480 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2023-06-01 | 2023-06-05 | 27,750 | — | $0 | 27,750 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2023-06-01 | 2023-06-05 | 13,900 | — | $0 | 62,600 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2022-12-16 | 2022-12-20 | 37,878 | — | $0 | 37,878 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | A Award deriv | 2022-06-16 | 2022-06-17 | 12,789 | — | $0 | 12,789 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2022-06-01 | 2022-06-03 | 5,000 | $3.60 | $18.0K | 48,700 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2022-02-25 | 2022-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2022-02-25 | 2022-03-01 | 12,500 | — | $0 | 43,700 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2021-07-11 | 2021-07-13 | 11,500 | — | $0 | 11,500 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 0 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 143,986 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | X Exercise deriv | 2021-04-27 | 2021-04-29 | 47,236 | — | $0 | 143,986 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | X Exercise deriv | 2021-04-27 | 2021-04-29 | 47,263 | $8.66 | $409.3K | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 120,447 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | X Exercise deriv | 2021-04-27 | 2021-04-29 | 13,756 | — | $0 | 120,447 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | X Exercise deriv | 2021-04-27 | 2021-04-29 | 13,756 | $8.19 | $112.7K | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 61,109 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other | 2021-04-27 | 2021-04-29 | 1,666 | — | $0 | 17,756 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 271 | $13.50 | $3.7K | 18,027 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 8,793 | — | $0 | 19,422 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other | 2021-04-27 | 2021-04-29 | 458 | — | $0 | 10,629 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 7,355 | — | $0 | 11,087 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 3,732 | — | $0 | 3,732 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 0 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2021-02-25 | 2021-03-01 | 16,400 | — | $0 | 16,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2021-02-25 | 2021-03-01 | 8,200 | — | $0 | 31,200 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-05-20 | 2,500 | — | $0 | 15,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-06-03 | 10,000 | — | $0 | 23,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-05-12 | 2020-05-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2020-03-18 | 2020-03-19 | 3,000 | $5.20 | $15.6K | 13,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-06-10 | 2019-06-12 | 2,500 | — | $0 | 10,000 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2019-05-22 | 2019-05-24 | 27,383 | — | $0 | 27,383 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-05-14 | 2019-05-15 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2018-11-14 | 2018-11-15 | 2,000 | $9.00 | $18.0K | 7,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-09-20 | 2018-09-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2018-09-07 | 2018-09-07 | 2,000 | $13.52 | $27.0K | 5,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-11 | 2018-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-11 | 2018-06-12 | 2,500 | — | $0 | 3,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-09-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-05 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2016-06-14 | 2016-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-05-26 | 2016-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 12,500 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2015-06-22 | 2015-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2014-06-17 | 2014-06-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 7,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-05-23 | 2013-05-28 | 2,000 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-05-23 | 2013-05-28 | 2,000 | $10.64 | $21.3K | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 4,000 | — | $0 | 4,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 2,000 | — | $0 | 2,000 | SEC↗ |